https://clinicaltrials.gov/ct2/show/NCT04056689?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=07%2F31%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
Study to Evaluate DNL151 in Subjects With Parkinson’s Disease
DESCRIPTION:
Condition: Parkinson Disease
Interventions: Drug: DNL151 low dose; Drug: DNL151 high dose; Drug: Placebo
Sponsor: Denali Therapeutics Inc.
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT04056689
FIRST POSTED:
Wed, 14 Aug 2019 12:00:00 EDT
LAST UPDATE POSTED:
08/14/19 07:51AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT04056689?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=07%2F31%2F2019&lupd_d=14&sort=nwst